News

FDA advisory panel recommends using bivalent COVID-19 shots for all doses

By Abigail Adcox
Published January 26, 2023 10:21pm ET
Add Washington Examiner on Google
FDA advisory panel recommends using bivalent COVID-19 shots for all doses
President Trump signed into law the FDA Reauthorization Act of 2017 on Friday. It reauthorizes a program in which drug and device makers pay the FDA a fee for every new product application, and the agency uses that money to hire more people and speed up approvals. (AP Photo/Andrew Harnik, File) | Andrew Harnik

A panel of independent experts that advises the Food and Drug Administration on vaccines has backed a proposal to use the same COVID-19 vaccine formula for both the two-dose primary vaccination series and boosters in an effort to simplify the country’s vaccine administration.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

COVID-19 FDA Vaccines